SecBot SecBot
PRESS-RELEASE ·Filed Nov 11, 2026

IRTC

iRhythm
NEUTRAL
Impact 3/10
Horizonweeks Processed5d 10h ago WireGlobeNewswire
Press release · Activist
Actionable Insight • Neutral

The buyback is discretionary and non-binding; monitor actual repurchase activity in future filings to gauge management's conviction. The authorization alone does not alter fundamentals.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1
Entry
$93.56
T+0 close · Nov 11, 2026 · via day close
Latest settled
−1.76%
T+1 · $91.91
Vs SPY
−1.40%
α at T+1
Next horizon
T+5
in 2d
  1. T+0 · Nov 12 $93.56entry
  2. T+1 · 4d ago −1.76%α −1.40% · $91.91
  3. T+2 · todayOpen
  4. T+5 · in 2d Pending
  5. T+20 · in 24d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

iRhythm's board authorized a $200 million share repurchase program, signaling confidence in the core business and the recently acquired VitalConnect. The buyback is discretionary and may be modified or suspended at any time.

Key Financial Metrics

Deal Value
$200.0M

Key Facts

  • Board approved up to $200 million in share repurchases on November 10, 2026
  • Repurchases may be made in open market, privately negotiated, or accelerated share repurchase transactions
  • Program may be modified, suspended, or terminated at any time at the Board's discretion
  • Funding expected from existing cash, cash equivalents, and ongoing operations
  • Company may enter into Rule 10b5-1 plans to facilitate repurchases

Financial Impact

$200 million buyback authorization, representing approximately 6.7% of the $3.0B market cap

share countcash

Risk Factors

  • Buyback may not be executed as planned or at all
  • Program can be modified, suspended, or terminated at any time
  • No obligation to repurchase any specific dollar amount or number of shares

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
95% bullish (22 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3401127

Track record

31 reports on IRTC

Performance horizon

8 of 11 bullish or bearish reports moved the stock their way by T+5. Best: +16.85% at T+60 after the Feb 25, 2026 report. 10 of 11 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $90.12 Now $90.83 +0.79% settles Nov 23
  2. Nov 13, 20263d ago 8-K Neutral 2/10 Entry $91.91 Now $90.83 −1.18% settles Nov 20
  3. Nov 12, 20264d ago SC 13G/A Neutral 3/10 Entry $93.56 Now $90.83 −2.92% settles Nov 19
  4. Nov 12, 20264d ago 8-K Neutral 4/10 Entry $93.56 Now $90.83 −2.92% settles Nov 19
  5. Nov 11, 20265d ago Press Release Neutral 3/10 Viewing Entry $93.56 Now $90.83 −2.92% settles Nov 19
  6. Nov 5, 202611d ago 8-K Mixed 6/10 No price data
  7. Nov 5, 202611d ago Press Release Bullish 6/10 Entry $90.22 to $91.91 Now $90.83 +0.68% ▲ +1.87% −0.72% vs SPY
  8. Oct 27, 202620d ago Institutional Cluster Mixed 4/10 Entry $123.99 to $134.00 Now $90.83 −26.74% ▲ +8.07% +8.79% vs SPY
  9. Oct 15, 20264w ago Press Release Neutral 1/10 Entry $108.66 Now $90.83 −16.41% No price data
  10. Oct 13, 20264w ago SC 13G/A Neutral 2/10 Entry $106.05 to $113.55 Now $90.83 −14.35% ▲ +7.07% +6.62% vs SPY
Showing 10 of 31

US Market Status

Market Closed · Opens in 6h 26m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 11, 2026